A popular case-control study to assess the relationship between gene polymorphisms and the risk of lymphoma done by the International Lymphoma Epidemiology (InterLymph) consortium in 2006 showed that there is no association between IL-6 promoter polymorphism (174G > C rs1800795) and the risk of NHL [16]. This evidence concerns the gene IL6 and lymphoma.